Arkolith/Insider Trading/HUMA/Form 4

Niklason Laura E

President, CEO and Director, DirectorHumacyte, Inc. (HUMA) · full profile →Form 4 · filed Aug 29, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.7M
Net Open-Market Flow
-$5.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 29, 2024Sell(S)352K$6.35$2.2M3.7M
Aug 28, 2024Sell(S)277K$6.47$1.8M4.0M
Aug 27, 2024Sell(S)253K$6.71$1.7M4.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001818382-24-000166) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML